Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

633
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
633
Disorders of Hemostasis01:24

Disorders of Hemostasis

737
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
737
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

6.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.1K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

3
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
3
Coagulation01:09

Coagulation

5.3K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.3K
Introduction to Hemostasis01:05

Introduction to Hemostasis

6.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Biologic modulation of ineffective erythropoiesis in thalassemia: mechanisms, clinical practice, and future targets.

Expert opinion on biological therapy·2026
Same author

When cure exists but access does not.

Nature medicine·2026
Same author

Novel phosphatase-based regulatory loop for HbF expression.

Blood·2026
Same author

How I manage luspatercept in transfusion-dependent beta-thalassemia.

HemaSphere·2026
Same author

Spirituality and cancer: quality of life, anxiety/depression and symptom severity.

BMJ supportive & palliative care·2025
Same author

From Science to Solidarity: A Two-Decade Collaboration in Thalassemia.

American journal of hematology·2025

相关实验视频

Updated: Jun 10, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

190

血红蛋白病变中的高凝血性:解码血栓性威胁

Rayan Bou-Fakhredin1,2, Maria Domenica Cappellini2, Ali T Taher3

  • 1Department of Clinical Sciences and Community, University of Milan, Milan, Italy.

American journal of hematology
|October 14, 2024
PubMed
概括
此摘要是机器生成的。

贝塔thalassemia和状细胞疾病导致高凝血状态,增加血栓形成的风险. 了解这些机制有助于为患者制定更好的预防和治疗策略.

更多相关视频

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

695

相关实验视频

Last Updated: Jun 10, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

190
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

695

科学领域:

  • 血液学 血液学 血液学
  • 血管生物学 血管生物学
  • 遗传学 是一个遗传学.

背景情况:

  • 贝塔 (β) - thalassemia和状细胞疾病 (SCD) 与高凝血状态有关.
  • 这种高凝血能力在这些血红蛋白病变中显著影响器官并发症和疾病严重程度.

研究的目的:

  • 为了描述β-血病和SCD中血栓形成的病变发生.
  • 为了确定驱动血红蛋白病变中的促凝剂概况的常见机制.
  • 对这些患者群体中血栓形成的当前预防和管理策略进行审查.

主要方法:

  • 在β-thalassemia和SCD中对血栓形成病变的文献综述.
  • 分析导致的因素,包括红细胞,红细胞质细胞,自由血红细胞和炎症性血管病变.
  • 综合关于常见的血凝剂机制和临床管理的信息.

主要成果:

  • 红细胞和红色红细胞在β-thalassemia和SCD中的血栓形成中起着至关重要的作用.
  • 自由血红,炎症性血管病变和脊髓切除术是对血栓形成风险的额外贡献者.
  • 常见的机制是导致血红蛋白病导致血栓事件的促凝状态的基础.

结论:

  • 了解高凝血的多面驱动因素对于改善预防和治疗策略至关重要.
  • 增强的知识将有助于开发用于β-thalassemia和SCD中血栓形成的新疗法.
  • 目前的预防和管理方法需要持续评估和潜在的增强.